NCT05000801View on ClinicalTrials.gov

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL

DC vaccine

Autologous/or HLA-matched donors' DCs loaded with WT1/TERT/survivin

Trial Locations (1)

100071

RECRUITING

Department of hematology, Beijing

All Listed Sponsors
lead

Affiliated Hospital to Academy of Military Medical Sciences

OTHER